StonvexLoading…
StonvexStonvexStonvexCore line items from OCG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.89M | $622.69K | $1.58M | $17.81M |
Operating Income | $-3.84M | $-3.20M | $-4.34M | $2.59M |
Net Income | $-3.86M | $-2.43M | $-3.60M | $3.24M |
EPS (Diluted) | $-107.26 | $-121.44 | $-556.29 | $0.77 |
Total Assets | $66.53M | $53.04M | $48.63M | $53.39M |
Total Liabilities | $1.89M | $3.13M | $3.08M | $3.77M |
Cash & Equivalents | $32.32M | $17.07M | $17.68M | $17.19M |
Free Cash Flow OCF − CapEx | Not available | $-4.07M | $3.43M | $-1.92M |
Shares Outstanding | 148.96K | 28.14K | 4.27M | 4.21M |